Visalytics
Visalytics
approved EB-2 (NIW)

Research Instructor

Biotechnology · India · 2022-05-06

Processing Time
195 days
Decision Date
2022-05-06
This case is from a publicly available case study. Case studies tend to feature successful outcomes and may not reflect the full range of petition results.

Proposed Endeavor

The petitioner proposes to continue developing genomic screening platforms and gene therapy-based approaches to facilitate the design of novel treatment modalities for cancer. This work focuses on identifying genetic factors that contribute to cancer development and progression using state-of-the-art molecular methods.

Framework Evaluation

3 of 3 criteria met
1 Substantial Merit and National Importance Met

The research addresses pressing global issues in cancer development and genetic factor identification.

2 Well-positioned to Advance the Endeavor Met

The petitioner's record of 16 publications and 417 citations establishes his recognized expertise and impact on the field.

3 Waiver of Job Offer and Labor Certification Met

The petitioner's elite level of attainment and the value of his work to the U.S. healthcare landscape justify the waiver.

Why This Petition Was Approved

The petition was approved based on 16 peer-reviewed scientific articles, 417 citations from 50 countries, and 26 completed peer reviews. The case was supported by 4 expert recommendation letters and evidence of funding from the NIH and the American Cancer Society, satisfying all three Dhanasar prongs.

Evidence

Evidence Types
Peer Reviewed Publications
Citations
Reference Letters Independent
Grants
Original Contributions
Judging Experience
Government Alignment

Similar Cases

Data Scientist

Biotechnology

WeGreened EB-2 (NIW) approved
71 days 2025-01-04
The petitioner proposes to interrogate multimodal genomic and clinical datasets from cancer patients to uncover key associations between genetic traits, clinical features, and therapeutic responses. This work aims to enable the development of individualized cancer treatment strategies and reduce the financial and human burden of cancer in the U.S.
View Case

Research Scientist

Information Technology · India

WeGreened EB-2 (NIW) approved
Texas 46 days 2025-06-09
The petitioner proposes to develop advanced computational algorithms to analyze genomic data for identifying mutations and variants that drive cancer progression. This work involves prioritizing and validating cancer driver genes and integrating these findings into clinical workflows to improve diagnosis accuracy and prognosis. The goal is to support personalized treatment strategies and reduce the impact of cancer on patients and the U.S. healthcare system.
View Case

Others

Biotechnology · Taiwan

WeGreened EB-2 (NIW) approved
Maryland 464 days 2022-05-21
The petitioner proposes to continue the full characterization of cellular and genetic mechanisms related to cancers that interact with their surrounding microenvironment. The work focuses on improving treatment strategies, identifying therapeutic targets to slow metastasis, and mitigating the economic costs associated with cancer care.
View Case

Assistant Professor

Healthcare · Pakistan

WeGreened EB-2 (NIW) approved
District of Columbia 3 days 2023-08-23
The petitioner proposes to continue her research in pathology with a focus on molecular pathology and personalized treatment strategies for breast and genitourinary cancers. Her work involves developing tissue microarray analysis techniques to extract genomic and immunohistochemical data for more accurate cancer diagnostics. She also aims to discover molecular markers for rare and treatment-resistant tumors, particularly in underserved populations.
View Case

Frequently Asked Questions

A approved EB-2 NIW (I-140) petition means USCIS determined the petitioner met the eligibility requirements. For appealed cases, "sustained" means the appeal reversed a prior denial. The petitioner can proceed to the next step in the immigration process.

Browse More Cases

More approved cases More Biotechnology cases More cases from India

Case data sourced from publicly available petition decisions and case studies. Decision date: 2022-05-06.

Browse all cases
View Original

At a Glance

Outcome approved
Processing 195 days
Criteria Met 3 / 3
Evidence Types 7

EB-2 (NIW) Case Data

Scraped Case Data

Total Cases 3,813
Success Rate 53.7%
Sustained 2,046
Dismissed 1,671

Related Pages

EB-2 (NIW) Overview EB-2 (NIW) in India All EB-2 (NIW) Cases EB-2 (NIW) Dashboard Endeavor Search

Get Case Insights

Compare your profile against thousands of real petition outcomes. Join the waitlist for personalized analysis.

Join Waitlist